SCHEMBL8974693

SCHEMBL8974693

[CH2]COC(=O)C1CCc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 5/20 0.50
KCNQ2 O43526 1/20 0.41
IDO1 P14902 2/20 0.40
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CRBN Q96SW2 1/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
TAS1R3 Q7RTX0 2/20 0.38
TAS1R1 Q7RTX1 2/20 0.38
TAS1R2 Q8TE23 2/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8975058 0.88 PIN1 (0.48) PIN1KCNQ2IDO1TSHRCRBN
SCHEMBL28742465 0.86 PIN1 (0.51) PIN1KCNQ2IDO1TSHRCRBN
SCHEMBL4720088 0.84 PIN1 (0.52) PIN1TSHRMTNR1AMTNR1BALDH1A1
SCHEMBL9463775 0.83 PIN1 (0.49) PIN1KCNQ2IDO1ALDH1A1
SCHEMBL29498272 0.82 PIN1 (0.57) PIN1KCNQ2IDO1CRBNTAS1R3
SCHEMBL1153666 0.79 PIN1 (0.60) PIN1KCNQ2IDO1TAS1R3TAS1R1
SCHEMBL29609016 0.79 PIN1 (0.60) PIN1KCNQ2IDO1TAS1R3TAS1R1
SCHEMBL1898510 0.79 PIN1 (0.54) PIN1KCNQ2IDO1CRBNCHRM2
SCHEMBL9540395 0.79 PIN1 (0.54) PIN1KCNQ2IDO1CRBNMTNR1A
SCHEMBL14143104 0.79 PIN1 (0.60) PIN1KCNQ2IDO1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0543919-B1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF CNS DISEASES SEARLE & CO (US) 1996-04-10 EP claimed
EP-0543919-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES. SEARLE & CO (US) 1993-06-02 EP claimed
WO-1992003131-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES G.D. SEARLE & CO. (US) 1992-03-05 WO claimed
EP-0543919-B1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF CNS DISEASES SEARLE & CO (US) 1996-04-10 EP disclosed
US-5462965-A Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases GD SEARLE & CO. (US) 1995-10-31 US disclosed
EP-0543919-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES. SEARLE & CO (US) 1993-06-02 EP disclosed
WO-1992003131-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES G.D. SEARLE & CO. (US) 1992-03-05 WO disclosed